Trace amines and their receptors
Trace amines are endogenous compounds classically regarded as comprising β-
phenylethyalmine, p-tyramine, tryptamine, p-octopamine, and some of their metabolites …
phenylethyalmine, p-tyramine, tryptamine, p-octopamine, and some of their metabolites …
Therapeutic potential of TAAR1 agonists in schizophrenia: evidence from preclinical models and clinical studies
Trace amine-associated receptor 1 (TAAR1) has emerged as a promising therapeutic target
for neuropsychiatric disorders due to its ability to modulate monoaminergic and …
for neuropsychiatric disorders due to its ability to modulate monoaminergic and …
[HTML][HTML] Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges
The discovery in 2001 of a G protein-coupled receptor family, subsequently termed trace
amine-associated receptors (TAAR), triggered a resurgence of interest in so-called trace …
amine-associated receptors (TAAR), triggered a resurgence of interest in so-called trace …
TAAR1 as an emerging target for the treatment of psychiatric disorders
J Liu, R Wu, JX Li - Pharmacology & Therapeutics, 2024 - Elsevier
Trace amines, a group of amines expressed at the nanomolar level in the mammalian brain,
can modulate monoamine transmission. The discovery of and the functional research on the …
can modulate monoamine transmission. The discovery of and the functional research on the …
The claustrum-prefrontal cortex pathway regulates impulsive-like behavior
The claustrum connects with a broad range of cortical areas including the prefrontal cortex
(PFC). However, the function of the claustrum (CLA) and its neural projections remains …
(PFC). However, the function of the claustrum (CLA) and its neural projections remains …
Common neurocircuitry mediating drug and fear relapse in preclinical models
Background Comorbidity of anxiety disorders, stressor-and trauma-related disorders, and
substance use disorders is extremely common. Moreover, therapies that reduce pathological …
substance use disorders is extremely common. Moreover, therapies that reduce pathological …
Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases
MD Schwartz, JJ Canales, R Zucchi… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: The trace amines, endogenous amines closely related to the biogenic amine
neurotransmitters, have been known to exert physiological and neurological effects for …
neurotransmitters, have been known to exert physiological and neurological effects for …
Trace amine-associated receptor 1 (TAAR1): Potential application in mood disorders: A systematic review
There is a need for innovation with respect to therapeutics in psychiatry. Available evidence
indicates that the trace amine-associated receptor 1 (TAAR1) agonist SEP-363856 is …
indicates that the trace amine-associated receptor 1 (TAAR1) agonist SEP-363856 is …
Role of trace amine-associated receptor 1 in nicotine's behavioral and neurochemical effects
Nicotine addiction and abuse remains a global health issue. To date, the fundamental
neurobiological mechanism of nicotine addiction remains incompletely understood. Trace …
neurobiological mechanism of nicotine addiction remains incompletely understood. Trace …
Ulotaront: a TAAR1/5-HT1A agonist in clinical development for the treatment of schizophrenia
M Højlund, CU Correll - Expert opinion on investigational drugs, 2022 - Taylor & Francis
Introduction Current antipsychotics are postsynaptic dopamine-2 (D2) receptor blockers,
which often, but not always, effectively improve acute psychotic symptoms and prevent …
which often, but not always, effectively improve acute psychotic symptoms and prevent …